FDA Approved: ASPARLAS — Supplemental Application (Servier Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for ASPARLAS (calaspargase pegol) from Servier Pharmaceuticals LLC, resulting in changes to the product labeling and/or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Asparlas (calaspargase pegol)

Snippet

SUPPL AP for ASPARLAS (CALASPARGASE PEGOL)